Two Hutchinson Center Scientists Receive a Total of $16.7 Million for Collaborative Stem Cel... (l work to generate ex vivo or outside ...)

Two Hutchinson Center Scientists Receive a Total of $16.7 Million for Collaborative Stem Cell Research

Date:10/7/2009

l work to generate "ex vivo," or outside the body, platelets and their precursors from embryonic stem cells for use as cell therapy.

Bernstein, along with Hutchinson Center/UW Cancer Consortium researchers and the University of Pennsylvania's Edward Morrisey, Ph.D., is using his $8.5 million award to determine how certain signaling pathways - ordered sequences of biochemical reactions inside cells - affect cardiac and blood-forming cell development and cardiac regeneration and repair. The team will also study whether these pathways can be harnessed for therapeutic applications. Drawing on Bernstein's success in expanding cord-blood stem cells, the researchers hope to refine methods for deriving therapeutically useful numbers of cells for transplantation and other treatments.

At Fred Hutchinson Cancer Research Center, our interdisciplinary teams of world-renowned scientists and humanitarians work together to prevent, diagnose and treat cancer, HIV/AIDS and other diseases. Our researchers, including three Nobel laureates, bring a relentless pursuit and passion for health, knowledge and hope to their work and to the world. For more information, please visit fhcrc.org.

    CONTACT
    Kristen Woodward
    206-667-2896
    kwoodwar@fhcrc.org

SOURCE Fred Hutchinson Cancer Research Center

SOURCE Fred Hutchinson Cancer Research Center
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2
Related medicine technology :

1. Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Successfully Completes Evaluation of AutoGenomics 2C9-VKORC1 Panel to Assess Warfarin Sensitivity
2. Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Successfully Completes Evaluation of AutoGenomics 2C9-VKORC1 Panel to Assess Warfarin Sensitivity
3. The Heart, Diabetes, And Weight Loss Centers of New York Introduce the New Science of Metabolic Diagnosis and Weight Management
4. Genasense(R) Data in Melanoma to be Presented in Opening Session at First Worldwide Melanoma Center Meeting of the European Association of Dermato-Oncology
5. Keeping the Data Center Clean: ATEN Launches Industry-First KVM Switches with Antimicrobial Nanocoating to Protect Products from Bacteria Surviving on Surfaces
6. Cepheid Announces Termination of Contract With the Centers for Disease Control and Prevention to Develop Rapid Point of Care Test for Avian Influenza
7. International Expert Group Initiates Largest Multi-center Phase III Trial to Evaluate NeuroAid(TM) in Stroke Recovery
8. Proteolix Initiates Multicenter Open-label Study of the Safety and Activity of Carfilzomib in Subjects With Relapsed Solid Tumors
9. Preimplantation Genetic Diagnosis International Society Refutes American Society of Reproductive Medicine Opinion - States Preimplantation Genetic Screening is Beneficial When Performed in Experienced Centers
10. M. D. Anderson Cancer Center to Lead Study of Surgery vs. CyberKnife(R) Radiosurgery for Operable Lung Cancer Patients
11. Leading Physicians Present Interim Results from Multi-Center Studies of VNUS ClosureFAST Catheter at VEITHsymposium

Post Your Comments:

(Date:11/20/2009)...swire/ -- Reportlinker.com announces that a new ma.... ,, Pipettes & Pipettors - A Global Marke.../p0164373/Pipettes--Pipettors---A-Global-Market-Pe...m=pr&utm_campaign=prnewswire ,, Pipettes ...ny research laboratory. Large-scale applications i...

(Date:11/20/2009)...ov. 20 Boston Scientific...t has received 510(k) clearance from the U.S. Food...l to market its WallFlex® Fully Covered Esoph...eal strictures (obstructions) caused by tumors in ...eal cancer. ,, (Photo: http://www.newscom.co...

(Date:11/20/2009)...ewswire-FirstCall/ -- Smith & Nephew ( SNN, LS...e the signing of a technology development contract... may lead to the creation of a fracture fixation s...he limbs of soldiers who sustain battlefield injur...h Projects Agency (DARPA), the central research an...

[0] Reportlinker Adds Pipettes & Pipettors - A Global Market Perspective [0] Boston Scientific Announces FDA Clearance and CE Mark for WallFlex(R) Fully Covered Esophageal Stent [0] Smith & Nephew Orthopaedics Selected to Develop New Technology for Treating Battlefield Injuries

...tho-McNeil Neurologics, a,division of Ortho-McNeil...at the U.S. Food and Drug Administration (FDA) has...iramate), based on studies submitted in,response t...use of TOPAMAX,in pediatric patients aged 1 to 24 ...to granting pediatric exclusivity, the FDA is cont...

...4 Alexza,Pharmaceuticals, Inc. (Nasdaq: ALXA ) a...ase 3 clinical trial with AZ-004 (Staccato(R) loxa...eing developed for the treatment,of acute agitatio...er.,Alexza believes the novel, non-invasive nature...ng from inhaled loxapine administration via the,St...

Other Medicine Technology:FDA Grants Pediatric Exclusivity for TOPAMAX(R), Extending the Marketing Exclusivity by Six Months 2 FDA Grants Pediatric Exclusivity for TOPAMAX(R), Extending the Marketing Exclusivity by Six Months 3 Alexza Initiates Second Phase 3 Clinical Trial for AZ-004 (Staccato(R) Loxapine) 2 Alexza Initiates Second Phase 3 Clinical Trial for AZ-004 (Staccato(R) Loxapine) 3 Alexza Initiates Second Phase 3 Clinical Trial for AZ-004 (Staccato(R) Loxapine) 4 Alexza Initiates Second Phase 3 Clinical Trial for AZ-004 (Staccato(R) Loxapine) 5 Alexza Initiates Second Phase 3 Clinical Trial for AZ-004 (Staccato(R) Loxapine) 6

FDA Grants Pediatric Exclusivity for TOPAMAX(R), Extending the Marketing Exclusivity by Six Months Alexza Initiates Second Phase 3 Clinical Trial for AZ-004 (Staccato(R) Loxapine)

(Date:11/20/2009)... supply, study finds , , FRIDAY, Nov. 20...f prescription drugs is up to one-third cheaper th...tudy. , U.S. researchers analyzed 26,852 prescr..., and found that patients who bought a three-month...rage 29 percent in out-of-pocket costs. After the ...

(Date:11/20/2009)...ed to continue, CDC says, , , FRIDAY, N...d States are seeing declines in H1N1 swine flu act...while the disease remains widespread in 43 states,.... , "We are beginning to see some declines in i... still a lot of influenza everywhere," Dr. Anne Sc...

(Date:11/20/2009)...ased food insecurity as many face problem of hunge...- Project Bread, the state,s leading anti-hunger o...nual status report on hunger in the Commonwealth. ...aused by high unemployment, point to 554,000 peopl... insecurity has found its way into middle class su...

(Date:11/20/2009)... Omnicell, Inc. (Nasdaq:... acute healthcare facilities, announced today the ...fray Healthcare Conference at the New York Palace... Randall A. Lipps, founder, chairman, president &a..., Date: Tuesday, December 1, 2009 ,, Time: ...

(Date:11/20/2009)...wswire-USNewswire/ -- The Louisiana Association ...ans could experience higher health care premiums a...by Congress should become law. ,, According to ...siana health plans have supported comprehensive he...al debate. Our plans have offered significant cha...

Breaking Medicine News(10 mins):Health News:Three-Month Supply Lowers Drug Costs 2 Health News:Swine Flu Declining in Some Parts of U.S. 2 Health News:Swine Flu Declining in Some Parts of U.S. 3 Health News:554,000 in Massachusetts Struggle to Put Food on the Table 2 Health News:554,000 in Massachusetts Struggle to Put Food on the Table 3 Health News:554,000 in Massachusetts Struggle to Put Food on the Table 4 Health News:Omnicell to Present at Piper Jaffray Healthcare Conference 2 Health News:Congressional Health Care Reform Proposals Would Make Health Care More Expensive, Reduce Benefits for Louisianians 2

[0] Three-Month Supply Lowers Drug Costs [0] Swine Flu Declining in Some Parts of U.S.[0] 554,000 in Massachusetts Struggle to Put Food on the Table [0] Omnicell to Present at Piper Jaffray Healthcare Conference [0] Congressional Health Care Reform Proposals Would Make Health Care More Expensive, Reduce Benefits for Louisianians

...shows amount in outer hair cell membranes affects ...ount of cholesterol in the outer hair cell membran... study concludes. , "We,ve known for a long time t...ing," senior author Dr. William Brownell, a profes...

...ars of follow-up, older women taking the newer dru...c. 14 (HealthDay News) -- The aromatase inhibitor ...d tamoxifen when it comes to preventing recurrence... a benefit, researchers said. , "It has been very...

...ber 14, 2007 A new review article from the journa...rug used to treat lymphoma, is now becoming used b...iseases. , Originally developed as the standard ...n dermatology and found that it successfully treat...

...c. 14 Veridex, LLC, a,Johnson & Johnson company, ...d the GeneSearch(TM) Breast Lymph Node (BLN) Assay..., In the December 24th issue of the magazine, ava... say, "doctors can,accurately test the sentinel no...

...ec. 14 The 10th Annual Customer,Experience Confer...ience,",sponsored by Best Practices, LLC,s Global ...ton Hotel in Phoenix, Ariz., Feb. 25-27, 2008. Thi...tition., Download "Using Quality to Improve the C...

... Combines Personal Responsibility and Public,Dolla...tt today announced the approval of a Medicaid waiv...nt an innovative health care proposal giving,appro...g applications for the new health care coverage, c...

Other Medicine News:Health News:Study Finds Cholesterol Fine-Tunes Hearing 2 Health News:Arimidex Beats Tamoxifen in Keeping Breast Cancer at Bay 2 Health News:Arimidex Beats Tamoxifen in Keeping Breast Cancer at Bay 3 Health News:TIME Magazine Names GeneSearch(TM) One of the Top 10 Medical Breakthroughs in 2007 2 Health News:TIME Magazine Names GeneSearch(TM) One of the Top 10 Medical Breakthroughs in 2007 3 Health News:TIME Magazine Names GeneSearch(TM) One of the Top 10 Medical Breakthroughs in 2007 4 Health News:Reserve 2008 Budget for Using Quality to Improve the Customer Experience 2 Health News:HHS Approves Medicaid Waiver to Create New Indiana Health Plan for Uninsured Hoosiers 2

Study Finds Cholesterol Fine-Tunes Hearing Arimidex Beats Tamoxifen in Keeping Breast Cancer at Bay Lymphoma drug used to treat skin disorders TIME Magazine Names GeneSearch(TM) One of the Top 10 Medical Breakthroughs in 2007 Reserve 2008 Budget for Using Quality to Improve the Customer Experience HHS Approves Medicaid Waiver to Create New Indiana Health Plan for Uninsured Hoosiers

Aescula LV Left-Heart Lead

B 3.2 Bipolar Ventricular Lead

Fineline

FLextend

Medicine Products:

Aescula LV Left-Heart Lead B 3.2 Bipolar Ventricular Lead Fineline FLextend

Two Hutchinson Center Scientists Receive a Total of $16.7 Million for Collaborative Stem Cel...(l work to generate ex vivo or outside ...),Health